Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
RA Capital Nexus Fund, L.P. bought 1,027,722 Artiva Biotherapeutics, Inc. shares (Form 4)
Traded Jun 9 to Jun 11, 2026 · Filed Jun 11, 2026
From Jun 9 to Jun 11, 2026, RA Capital Nexus Fund, L.P. (Director) bought 1,027,722 Artiva Biotherapeutics, Inc. shares at an average US$7.44 for US$7.65M, leaving 16,231,717 shares. Filed Jun 11, 2026 (Form 4).
- Bought
- 1,027,722 shares
- Price
- US$7.44 average (US$6.91 to US$7.91)
- Value
- US$7.65M
- Holding after
- 16,231,717 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Common Stock | Buy | 479,039 | US$6.91 | 15,683,034 | Indirect |
| Jun 10, 2026 | Common Stock | Buy | 103 | US$7.00 | 15,683,137 | Indirect |
| Jun 11, 2026 | Common Stock | Buy | 548,580 | US$7.91 | 16,231,717 | Indirect |
Source
Related
- Artiva Biotherapeutics, Inc.
- RA Capital Nexus Fund, L.P.
- Artiva Biotherapeutics, Inc. shareholders
- Form 4/A · RA Capital Nexus Fund, L.P. · Jul 23, 2026
- Form 4 · Aslan Fred · Oct 7, 2026
- Form 4 · Aslan Fred · Oct 6, 2026
- Form 4 · Banerjee Subhashis · Oct 6, 2026
- Form 4 · Bush Jennifer · Oct 6, 2026
- Form 4 · Horan Christopher · Oct 6, 2026